Collage photo of Nina Niu Sanford and Kristen Ciombor
Aug 27, 2025, 18:43
Nina Niu Sanford: Kristen Ciombor Discusses the Pros and Cons of ctDNA Testing in Cancer Care
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X:
” ‘We’re in this weird space where it’s technically available and costs aren’t passed onto patients…but if NCCN was going to recommend it, what would that cost the healthcare system and is it worth it?’
Kristen Ciombor opines on NCCN recs and discusses the pros/cons of ctDNA testing with her patients.”
Proceed to the video attached to the post.
More posts featuring Nina Niu Sanford.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 27, 2025, 18:20
Aug 27, 2025, 18:03
Aug 27, 2025, 17:48
Aug 27, 2025, 16:59
Aug 27, 2025, 16:34
Aug 27, 2025, 16:00
Aug 27, 2025, 15:55
Aug 27, 2025, 15:53
Aug 27, 2025, 15:52